Astragalus Extract Market Size, Share, Growth, and Industry Analysis, By Type (Astragalus Polysaccharide,Astragaloside IV), By Application (Healthy Food,Pharmaceutical Industry,Feed Additives,Other), Regional Insights and Forecast to 2035

Astragalus Extract Market Overview

The global Astragalus Extract Market size is projected to grow from USD 20.27 million in 2026 to USD 20.94 million in 2027, reaching USD 27.32 million by 2035, expanding at a CAGR of 3.3% during the forecast period.

The global market for Astragalus Extract is witnessing substantial consumption and distribution worldwide. In 2024, the global market value for Astragalus extract including root-derived extracts was estimated at around USD 300 million. Asia-Pacific accounts for a major portion: Asia-Pacific region holds close to 48% of global market value in 2024, representing roughly USD 580 million scaled when considering underlying root and derivative markets. The global market for Astragalus-root and membranaceus extract sees widespread adoption across dietary supplements, pharmaceuticals, functional foods, cosmetics, and nutraceutical formulations demonstrating the broad-based demand for Astragalus Extract in global supply and consumption channels.

Within the United States, demand for Astragalus Extract remains robust, driven by growing consumer interest in natural supplements and preventive healthcare. North America led by the U.S. accounted for roughly 22% of the global Astragalus extract market value in 2024. In the broader Astragalus supplements market, North America’s share was estimated at approximately 40% in 2023. The U.S. dominance is supported by established dietary supplement infrastructure, widespread distribution networks (both online and offline), and rising adoption of botanical extracts such as Astragalus in natural health products across adult and aging-population segments.

What is Astragalus Extract?

Astragalus Extract is a natural herbal extract derived primarily from the root of Astragalus membranaceus, a medicinal plant widely used in traditional herbal medicine. It is commonly utilized in dietary supplements, pharmaceuticals, functional foods, cosmetics, and nutraceutical products due to its immune-boosting, anti-inflammatory, and antioxidant properties. The extract contains active compounds such as polysaccharides and astragalosides, which are believed to support overall wellness, improve immunity, and promote preventive healthcare. Growing consumer preference for plant-based and natural health products continues to drive the popularity of Astragalus Extract globally.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: 70% of adults globally now actively seek plant-based supplements like Astragalus to boost immunity.
• Major Market Restraint: 80% of global Astragalus supply originates from a single region (China’s Loess Plateau), where growing zones have shrunk by 15–20% over the past decade.
• Emerging Trends: 92–95% bioactive compound retention achieved through advanced extraction methodologies like ultrasonic-assisted extraction and supercritical CO₂ methods, up from 70% via conventional extraction.
• Regional Leadership: Asia-Pacific contributes 48% of global market value in 2024; this dominance underscores regional leadership in both production and consumption of Astragalus Extract.
• Competitive Landscape: Two Chinese companies, collectively accounting for 28% of domestic production capacity, lead production: XI'AN GAOYUAN BIO-CHEM and World-way Biotech.
• Market Segmentation (2023): The “Root Extract / Type 1” segment accounted for 42% of total market share; capsule-based extract sub-segment is the fastest-growing due to convenience.
• Recent Development: Over 156 GMP-certified extraction facilities were operating in China around 2023–2024, with 68% of Chinese astragalus extract exports meeting international quality standards.

Latest Trends

The global Astragalus Extract market is experiencing shifting consumption patterns and evolving production technologies. Recent industry data indicates that capsule-based extracts have surged, now representing a significant and growing share of global demand due to consumer preference for convenient supplement formats. Meanwhile, the pharmaceutical industry remains a dominant application segment in 2023, pharmaceuticals accounted for around 55% of total market share underscoring Astragalus Extract’s growing acceptance beyond traditional herbal supplements toward therapeutic uses.

Technological advancements are also reshaping market dynamics: modern extraction methods such as ultrasonic-assisted extraction (UAE) and supercritical CO₂ extraction are achieving bioactive compound retention rates of 92–95%, substantially higher than the 70% retention seen with conventional methods. These advances are motivating manufacturers to invest in upgraded production facilities collectively, investments exceeding USD 50 million have been reported towards precision extraction capabilities for standardized Astragalus Extracts.

Another trend is the expansion of functional-food and beverage applications. In regions such as Asia-Pacific, where herbal medicinal traditions remain strong, new astragalus-infused functional beverages, plant-based protein supplements, and fortified food products are emerging as key growth areas. Regulatory acceptance in Western markets is also enabling Astragalus Extract to reach broader consumer bases, albeit with stricter quality and standardisation requirements.

Market Dynamics

DRIVER

"Rising demand for natural immune-boosting supplements."

In recent years, global consumer behavior has increasingly shifted toward preventive healthcare and natural wellness solutions. For instance, more than 70% of adults globally are now actively seeking plant-based supplements fueling demand for Astragalus Extract. The recognized immunomodulatory and anti-inflammatory properties of Astragalus bioactive compounds specifically polysaccharides and saponins have gained traction in both traditional and modern healthcare systems.

As a result, manufacturers are integrating Astragalus Extract into dietary supplements, functional foods, pharmaceuticals, and wellness products worldwide. The rising prevalence of chronic diseases and increased health consciousness post-pandemic further amplify this demand. This widespread health awareness is translating into higher consumption volumes in China alone, annual Astragalus membranaceus root consumption reportedly reached 35 million kg per year in 2021 and 2022.

RESTRAINT

"Supply chain vulnerabilities and raw material constraints."

The global Astragalus Extract market faces notable supply-side constraints. Over 80% of the global supply originates from a single geographic region China’s Loess Plateau which has seen a reduction in optimal cultivation zones by 15–20% over the past decade due to environmental and climatic factors. The crop’s cultivation cycle often 3–5 years adds to the supply challenge, leading to supply-demand mismatches; premium-grade roots have experienced price volatility exceeding 40% year-over-year.

Moreover, the lack of uniform global quality standards complicates international trade. Many astragalus extracts vary in bioactive compound concentration owing to more than 50 active compounds in raw roots, yet only 2–3 marker compounds are monitored under current pharmacopeial standards. This variability has led to recurring product recalls about 15–20% annual recall rate in regulated markets due to potency inconsistencies.

OPPORTUNITY

"Expansion into functional foods, nutraceuticals, and pharmaceutical-grade formulations."

Given rising health consciousness and demand for preventive health solutions, there is high opportunity for Astragalus Extract to expand beyond traditional supplements into functional food, beverage, and pharmaceutical sectors. Recent shifts show functional-food applications such as fortified beverages and plant-based milk leveraging Astragalus Extract’s adaptogenic and immune-supportive properties.

Additionally, pharmaceutical-grade standardization through advanced extraction methods achieving 92–95% bioactive retention opens possibilities for integration into clinically validated nutraceutical and therapeutic products. As quality assurance protocols and regulatory acceptance improve globally, manufacturers and investors can capitalize on new product segments targeting aging populations, preventive healthcare, and wellness markets.

CHALLENGE

"Regulatory complexity and quality standardization."

A major challenge for market participants is the heterogeneity of regulatory frameworks across regions. In many international markets, botanical extracts like Astragalus encounter divergence in classification dietary supplement in some, novel food or botanical drug in others leading to uncertain regulatory paths and delayed product approvals.

Further, inconsistent extract profiles due to variable raw material quality and extraction methods can result in potency variation, undermining product reliability. This affects consumer trust and may trigger regulatory scrutiny; some markets record 30–35% rejection rates for shipments lacking rigorous heavy-metal/pesticide testing or standardization protocols.

For small and medium enterprises, these regulatory burdens long approval timelines and high compliance costs can deter market entry, limiting market growth and innovation potential, especially in Western markets.

Why is the Astragalus Extract Industry experiencing rapid growth?

The Astragalus Extract industry is experiencing strong growth due to rising global demand for natural immunity-boosting and preventive healthcare products. Consumers are increasingly seeking plant-based supplements and herbal wellness solutions to support immune health, reduce inflammation, and improve overall well-being. The growing popularity of functional foods, nutraceuticals, herbal beverages, and clean-label cosmetics is further expanding the use of Astragalus Extract across multiple industries. Additionally, advancements in extraction technologies and increasing acceptance of botanical ingredients in modern healthcare are accelerating market expansion worldwide.

Segmentation Analysis

The global Astragalus Extract market can be segmented by type and application, each with distinct performance dynamics.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

By Type

Astragalus Polysaccharide Extract: This type emphasizes high polysaccharide content, valued for immunomodulatory effects and often used in dietary supplements and functional food formulations. Demand for polysaccharide-rich extracts has spurred adoption among health-conscious consumers, especially in regions that favor natural immune-support products. Global consumption of Astragalus root in China reached approximately 35 million kg per year in 2021–2022, indicating strong raw-material utilization for polysaccharide extraction.

Astragaloside IV Extract: This type focuses on the saponin compound astragaloside IV, considered a key active phytochemical with therapeutic potentials. Recent industry investment into advanced extraction methods has focused on maximizing astragaloside IV yield with technologies like ultrasonic-assisted extraction and supercritical CO₂ enabling 92–95% retention of bioactive compounds. Pharmaceutical-grade astragaloside IV extracts are increasingly used in research-driven nutraceuticals and functional formulations, especially where standardized potency is required.

By Application

Healthy Food & Dietary Supplements: Astragalus Extract is widely used in supplements and functional food products for immune support, wellness, and preventive health, leveraging polysaccharide-based extracts. This segment benefits from high consumer interest in plant-based natural supplements and rising health awareness.

Pharmaceutical Industry: Extracts particularly standardized astragaloside IV formulations are increasingly incorporated into pharmaceutical or nutraceutical products aimed at immune support, anti-inflammatory, or cardiovascular wellness applications. This segment accounted for approximately 55% of global application share in 2023.

Feed Additives: Although less documented in recent data, some segments of the market consider Astragalus Extract for animal nutrition or feed additives, aligning with broader interest in botanical additives for livestock health and natural growth promoters.

Other: These include cosmetics, personal care products, and energy/functional beverages. Growth in clean-label beauty trends and natural cosmetic formulations has led to increasing inclusion of Astragalus Extract in anti-aging, skin-care, and wellness products.

Which segment is expected to witness the fastest growth?

The healthy food, dietary supplements, and pharmaceutical application segments are expected to witness the fastest growth in the Astragalus Extract market. Increasing consumer awareness regarding immunity support and preventive healthcare is driving demand for Astragalus-based supplements and functional food products. In addition, pharmaceutical-grade extracts and functional beverages infused with Astragalus are gaining popularity due to their perceived health benefits. Capsule-based extract products are also emerging as a rapidly growing segment because of their convenience and ease of consumption.

Regional Outlook

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

North America

North America, led by the United States, holds a significant slice of the global Astragalus Extract market. In 2023, North America accounted for approximately 32% of the global Astragalus Root Extract market share. This region benefits from high consumer awareness about natural supplements, a mature dietary supplement industry, and well-established distribution networks including online and offline channels.

U.S. consumers increasingly favour adaptogenic and botanical supplements as part of preventive healthcare regimes, especially for immune support, wellness, and aging-related health maintenance. The demand spans adults and elder demographics, driving a strong base for Astragalus-based formulations. Regulatory clarity under FDA for dietary supplements helps in building consumer confidence, though many producers adhere to stringent quality standards to address potency consistency and safety.

Pharmaceutical-grade astragalus extracts are gaining interest in North America, as research institutions and nutraceutical firms explore applications in immunity enhancement, stress support, and complementary therapy formulations. However, higher price points compared to synthetic alternatives and supply chain dependencies (on raw materials often sourced from Asia) remain challenges that can limit mass-market penetration beyond urban and health-conscious consumer segments.

Europe

In Europe, the Astragalus Extract market commands a significant share around 21% regionally (per 2023 data), placing it as a key market after North America and Asia-Pacific. The market growth is driven by rising consumer preference for natural and herbal supplements, along with increasing interest in preventive health, holistic wellness, and clean-label products. Countries such as Germany, France, and the United Kingdom are leading adopters of Astragalus-based formulations, especially within natural health products, nutraceuticals, and skin-care/cosmetic segments.

European regulatory environments including stringent quality, labelling, and novel-food authorization requirements pose entry barriers but also elevate consumer trust in compliant, standardized products. This regulatory rigor incentivizes manufacturers to adopt advanced extraction techniques and rigorous quality assurance protocols, which improve product consistency and support market credibility. As a result, European companies are increasingly sourcing authentic, GMP-certified astragalus extracts (often imported), and investing in R&D for pharmaceutical-grade applications, including anti-aging and cardiovascular wellness. Demand also stems from aging populations seeking natural alternatives to conventional pharmaceuticals.

Asia-Pacific

Asia-Pacific remains the dominant region for Astragalus Extract in 2024, this region accounted for approximately 48% of global market value. The region is deeply rooted in traditional medicine practices, especially in China, where herbal medicine practices involving Astragalus membranaceus are widespread. Large-scale cultivation and well-established supply chains provide the region with a cost advantage and raw-material availability.

China is the largest producer, with annual Astragalus root consumption reaching 35 million kg per year in 2021 and 2022. This high availability fuels both domestic consumption and export. Many Asian countries including Japan, South Korea, India, and countries in Southeast Asia contribute to growing demand due to rising disposable incomes, increasing urbanization, and growing health awareness.

In Asia-Pacific, astragalus extracts are widely used not only in dietary supplements but also in functional foods, traditional medicine, and cosmetics. The convergence of traditional knowledge and modern extraction technologies (such as ultrasonic-assisted extraction and supercritical CO₂ extraction) is driving premiumization and standardization of products. Manufacturers in this region benefit from local raw-material access and relatively lower production costs, making Asia-Pacific both a production hub and a major consumption base for Astragalus Extract worldwide.

Middle East & Africa

The Middle East & Africa currently represents a smaller share of the global Astragalus Extract market approximately 8% in 2023 across root-extract product lines. However, this region shows potential for growth as health awareness increases and demand for natural supplements rises, driven by affluent and urbanized populations in Gulf Cooperation Council (GCC) countries and increased influence of global wellness trends.

Imports from established producers (primarily in Asia-Pacific) supply much of the tasteless demand, given limited local cultivation capacity. As regulatory frameworks evolve to accommodate herbal supplements, manufacturers and distributors see an opportunity to enter niche markets targeting expatriate communities and health-conscious consumers. The region’s growth potential will depend heavily on improved supply-chain logistics, consistent quality standards, and increased consumer education about benefits of botanical extracts such as Astragalus Extract.

Which region holds the largest market share?

Asia-Pacific holds the largest share of the global Astragalus Extract market due to its strong traditional herbal medicine practices, large-scale cultivation, and well-established manufacturing infrastructure. Countries such as China, Japan, South Korea, and India play a major role in both production and consumption of Astragalus-based products. The region benefits from abundant raw material availability, growing health awareness, increasing demand for herbal supplements, and expanding applications in functional foods, pharmaceuticals, and cosmetics, making Asia-Pacific the leading market globally.

List of Top Astragalus Extract Companies

• Euromed SA
• XI`AN GAOYUAN BIO-CHEM
• World-way Biotech
• Zhe Jiang Skyherb Biotechnology
• Xinxiang Bokai Biological
• Acetar Bio-Tech
• Ningxian hengrui kang biological
• Shaanxi Jiahe Phytochem
• Xi'an Rainbow Biotech
• CHANGSHA ORGANIC HERB
• Xi`an Green Spring Technology
• Inner Mongolia Ever Brilliance Biotechnology

Top two companies with highest market share:

• XI`AN GAOYUAN BIO-CHEM accounts for significant share of China’s domestic production capacity (part of the 28% capacity share reported in 2024).
• World-way Biotech together with XI’AN GAOYUAN, represents the dominant producers in China and leads supply to both domestic and export markets.

Investment Analysis and Opportunities

Investments in the global Astragalus Extract market present compelling opportunities, especially given rising demand for natural immunity-boosting and wellness products. Considering that Asia-Pacific accounts for nearly 48% of global market value, investors focusing on cultivation zones and extraction capabilities in this region particularly in China, India, and Southeast Asian countries may benefit from lower raw-material and labor costs.

Growing adoption in the pharmaceutical and functional foods sectors adds further investment appeal. With pharmaceuticals constituting roughly 55% of global application share, there is strong potential for developing high-margin, standardized astragaloside IV and polysaccharide extracts for therapeutic and preventive health markets.

The advancement of extraction technologies (e.g., ultrasonic-assisted extraction, supercritical CO₂ extraction) with 92–95% bioactive retention enhances product quality and value proposition. Investors who allocate capital toward modern extraction facilities or partner with existing GMP-certified producers can capture growth in both established and emerging markets.

Moreover, the shift toward functional foods, nutraceuticals, and clean-label cosmetics broadens the addressable market. Entry into emerging regions such as Middle East & Africa where current share is modest offers first-mover advantages as consumer awareness increases. Strategic investments in standardization, certification, and quality control can build brand trust, enabling expansion across diverse global markets.

New Product Development

The global Astragalus Extract industry is experiencing heightened innovation, driven by demand for standardized, high-potency extracts and diversified application formats. Recent product development efforts focus on extraction technologies: advanced methods such as ultrasonic-assisted extraction (UAE) and supercritical CO₂ extraction are increasingly adopted, achieving bioactive compound retention rates of 92–95%, compared to 70% with conventional methods. These improvements enable manufacturers to produce standardized astragaloside IV and polysaccharide extracts, offering consistent potency and quality suited for pharmaceutical-grade formulations.

New formats beyond capsules and powders are emerging: functional beverages, fortified plant-based drinks, and ready-to-drink energy-health beverages incorporating Astragalus Extract are entering markets in both Asia-Pacific and Western countries.

In cosmetics and personal care, producers are developing topical formulations harnessing Astragalus Extract’s antioxidant and adaptogenic properties targeting anti-aging, skin vitality, and wellness-conscious consumers.

Furthermore, pharmaceutical-grade Astragalus Extracts standardized for astragaloside IV content are being integrated into research-backed nutraceuticals aimed at immune support, cardiovascular health, and anti-inflammatory therapies, reflecting a convergence of traditional herbal medicine with modern pharmaceutical standards.

This wave of product innovation is expanding the addressable market across multiple industries, including supplements, functional foods, cosmetics, and pharmaceuticals, thereby driving broader adoption and higher value extraction across the global Astragalus market.

Five Recent Developments (2023–2026)

• In 2024, over 156 GMP-certified extraction facilities were reported to be operating in China for Astragalus Extract production, significantly increasing capacity and export-ready supply.
• Advanced extraction technologies ultrasonic-assisted extraction and supercritical CO₂ extraction achieved bioactive retention rates of 92–95%, improving standardization and enabling pharmaceutical-grade Astragalus products.
• The pharmaceutical industry increased incorporation of Astragalus Extract into immune-support formulations, making pharmaceuticals the dominant application segment with 55% global share in 2023.
• Growth in functional food and beverage formulations: manufacturers launched new plant-based drinks and energy-health beverages fortified with Astragalus Extract, especially in Asia-Pacific and Western markets.
• Export-quality certification rose: approximately 68% of Astragalus extract exports from China in 2024 met international quality and safety standards, boosting global trade and market acceptance.

Report Coverage

This comprehensive market report on Astragalus Extract Global Market Analysis covers global and regional market dynamics, segmentation, competitive landscape, investment opportunities, product development and recent industry developments. It encompasses data from 2022 through 2026 with forward-looking projections, capturing supply-side factors such as cultivation and extraction capacity, and demand-side trends including dietary supplements, pharmaceutical integration, functional foods, cosmetics, and feed additives.

The report segments the market by Type (e.g., polysaccharide-rich extracts, astragaloside IV-rich extracts), by Application (healthy food & dietary supplements; pharmaceutical industry; feed additives; other applications such as cosmetics and functional beverages), and by Region (North America; Europe; Asia-Pacific; Middle East & Africa; Latin America as relevant background).

It includes a detailed Regional Outlook, presenting regional market shares and performance metrics for instance, Asia-Pacific’s 48% share, North America’s 32% share of root-extract market, and Europe’s 21% share thereby offering geographic insights for B2B stakeholders seeking market entry or expansion. The report also profiles key companies in the market, highlighting leading manufacturers such as XI`AN GAOYUAN BIO-CHEM and World-way Biotech, and their relative market dominance and production capacities.

Additionally, the report explores Market Dynamics including drivers, restraints, opportunities, and challenges; Investment Analysis, showcasing potential growth areas; New Product Development, detailing advancements in extraction technologies and product formats; and Recent Developments, listing notable events between 2023–2026 that influence market trajectory.

This Astragalus Extract Market Report is designed for B2B audiences, including manufacturers, distributors, investors, and strategic planners looking for data-driven insights into supply chains, competitive positioning, product innovation, regional opportunities, and market segmentation for Astragalus Extract globally.

Astragalus Extract Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 20.27 Million in 2026
Market Size Value By	USD 27.32 Million by 2035
Growth Rate	CAGR of 3.3% from 2026-2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Astragalus Polysaccharide Astragaloside IV By Application : Healthy Food Pharmaceutical Industry Feed Additives Other
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample